{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:20:44Z","timestamp":1775467244606,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T00:00:00Z","timestamp":1274400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s10067-010-1485-4","type":"journal-article","created":{"date-parts":[[2010,5,19]],"date-time":"2010-05-19T23:40:13Z","timestamp":1274312413000},"page":"1455-1459","source":"Crossref","is-referenced-by-count":12,"title":["A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review"],"prefix":"10.1007","volume":"29","author":[{"given":"Ioanna","family":"Saougou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalampos","family":"Papagoras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora E.","family":"Markatseli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros A.","family":"Drosos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,21]]},"reference":[{"key":"1485_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/ard.2006.058735","volume":"66","author":"PV Voulgari","year":"2007","unstructured":"Voulgari PV, Venetsanopoulou AI, Epagelis EK, Alamanos Y, Takalou I, Drosos AA (2007) Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience. Ann Rheum Dis 66:270\u2013271","journal-title":"Ann Rheum Dis"},{"key":"1485_CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.semarthrit.2007.07.003","volume":"37","author":"PV Voulgari","year":"2008","unstructured":"Voulgari PV, Venetsanopoulou AI, Exarchou SA, Alamanos Y, Tsifetaki N, Drosos AA (2008) Sustained clinical response and high infliximab survival in psoriatic arthritis patients: a 3-year long-term study. Semin Arthritis Rheum 37:293\u2013298","journal-title":"Semin Arthritis Rheum"},{"key":"1485_CR3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218\u201327","journal-title":"Arthritis Rheum"},{"key":"1485_CR4","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000185335","volume":"51","author":"FX Thierry","year":"1989","unstructured":"Thierry FX, Vernier I, Dueymes JM, Roche H, Canal P, Meeus F et al (1989) Acute renal failure after high-dose methotrexate therapy. Role of hemodialysis and plasma exchange in methotrexate removal. Nephron 51:416\u2013417","journal-title":"Nephron"},{"key":"1485_CR5","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/S0272-6386(96)90384-4","volume":"28","author":"SM Wall","year":"1996","unstructured":"Wall SM, Johansen MJ, Molony DA, DuBose TD Jr, Jaffe N, Madden T (1996) Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis 28:846\u2013854","journal-title":"Am J Kidney Dis"},{"key":"1485_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/art.1780390214","volume":"39","author":"S Gutierrez-Ure\u00f1a","year":"1996","unstructured":"Gutierrez-Ure\u00f1a S, Molina JF, Garc\u00eda CO, Cu\u00e9llar ML, Espinoza LR (1996) Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 39:272\u2013276","journal-title":"Arthritis Rheum"},{"key":"1485_CR7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.1780330724","volume":"33","author":"MH Ellman","year":"1990","unstructured":"Ellman MH, Ginsberg D (1990) Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis. Arthritis Rheum 33:1060\u20131061","journal-title":"Arthritis Rheum"},{"key":"1485_CR8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/1529-0131(200005)43:5<1185::AID-ANR30>3.0.CO;2-V","volume":"43","author":"WW Chatham","year":"2000","unstructured":"Chatham WW, Morgan SL, Alarc\u00f3n GS (2000) Renal failure: a risk factor for methotrexate toxicity. Arthritis Rheum 43:1185\u20131186","journal-title":"Arthritis Rheum"},{"key":"1485_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.331.7511.293-a","volume":"331","author":"GR Aronoff","year":"2005","unstructured":"Aronoff GR (2005) Dose adjustment in renal impairment: response from drug prescribing in renal failure. BMJ 331:293\u2013294","journal-title":"BMJ"},{"key":"1485_CR10","first-page":"989","volume":"132","author":"J Vega","year":"2004","unstructured":"Vega J, de L Rodriguez M, Vasquez A, Torres C (2004) Bone marrow aplasia during hemodialysis successfully treated with cyclosporine. Report of one case. Rev Med Chil 132:989\u2013994","journal-title":"Rev Med Chil"},{"key":"1485_CR11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00296-008-0826-y","volume":"29","author":"WS Chen","year":"2009","unstructured":"Chen WS, Young AH, Wang HP, Huang DF (2009) Hemolytic uremic syndrome with ischemic glomerulonephropathy and obliterative vasculopathy in a systemic sclerosis patient treated with cyclosporine-A. Rheumatol Int 29:821\u2013824","journal-title":"Rheumatol Int"},{"issue":"suppl","key":"1485_CR12","first-page":"13","volume":"74","author":"I Nestorov","year":"2005","unstructured":"Nestorov I (2005) Clinical pharmacokinetics of tumor necrosis factor antagonists. J Rheumatol 74(suppl):13\u201318","journal-title":"J Rheumatol"},{"key":"1485_CR13","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","volume":"20","author":"MB Stokes","year":"2005","unstructured":"Stokes MB, Foster K, Markowitz GS, Ebrahimi F, Hines W, Kaufman D et al (2005) Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20:1400\u20131406","journal-title":"Nephrol Dial Transplant"},{"key":"1485_CR14","first-page":"137","volume":"61","author":"AA Broeder den","year":"2003","unstructured":"den Broeder AA, Assmann KJ, van Riel PL, Wetzels JF (2003) Nephrotic syndrome as a complication of anti-TNF alpha in a patient with rheumatoid arthritis. Neth J Med 61:137\u2013141","journal-title":"Neth J Med"},{"key":"1485_CR15","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/ndt\/gfi180","volume":"20","author":"G Chin","year":"2005","unstructured":"Chin G, Luxton G, Harvey JM (2005) Infliximab and nephrotic syndrome. Nephrol Dial Transplant 20:2824\u20132826","journal-title":"Nephrol Dial Transplant"},{"key":"1485_CR16","first-page":"636","volume":"29","author":"R Singh","year":"2002","unstructured":"Singh R, Cuchacovich R, Huang W, Espinoza LR (2002) Infliximab treatment in a patient with rheumatoid arthritis on hemodialysis. J Rheumatol 29:636\u2013637","journal-title":"J Rheumatol"},{"key":"1485_CR17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/rheumatology\/kei264","volume":"45","author":"M Hammoudeh","year":"2006","unstructured":"Hammoudeh M (2006) Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis. Rheumatology (Oxford) 45:357\u2013359","journal-title":"Rheumatology (Oxford)"},{"key":"1485_CR18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-135-1-200107030-00010","volume":"135","author":"AM Yee","year":"2001","unstructured":"Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27\u201331","journal-title":"Ann Intern Med"},{"key":"1485_CR19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1136\/ard.2006.069211","volume":"66","author":"AJ Hueber","year":"2007","unstructured":"Hueber AJ, Tunc A, Schett G, Manger B (2007) Anti-tumour necrosis factor alpha therapy in patients with impaired renal function. Ann Rheum Dis 66:981\u2013982","journal-title":"Ann Rheum Dis"},{"key":"1485_CR20","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/art.11163","volume":"48","author":"JE Gottenberg","year":"2003","unstructured":"Gottenberg JE, Merle-Vincent F, Bentaberry F, Allanore Y, Berenbaum F, Fautrel B et al (2003) Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy. Arthritis Rheum 48:2019\u20132024","journal-title":"Arthritis Rheum"},{"key":"1485_CR21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/rheumatology\/keg361","volume":"42","author":"V Ortiz-Santamaria","year":"2003","unstructured":"Ortiz-Santamaria V, Valls-Roc M, Sanmart\u00ed M, Olive A (2003) Anti-TNF treatment in secondary amyloidosis. Rheumatology (Oxford) 42:1425\u20131426","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-010-1485-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-010-1485-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:41Z","timestamp":1559119901000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-010-1485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,21]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1485"],"URL":"https:\/\/doi.org\/10.1007\/s10067-010-1485-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,21]]}}}